GE HealthCare will acquire the remaining 50% stake in Nihon Medi-Physics, enabling it to fully own the Japanese ...

NMP's product range includes GE HealthCare radiopharmaceuticals, which are essential for imaging in cardiology, oncology, and ...

GE Healthcare has identified radiopharmaceuticals as a growth driver for the company and Japan as a key market.

智通财经获悉，GE HealthCare(GEHC.US)已同意从Sumitomo Chemical手中收购Nihon ...

智通财经获悉，GE HealthCare (GEHC.US)已同意从Sumitomo Chemical手中收购Nihon Medi-Physics (NMP)剩余50%的股份，旨在获得这家日本放射性制药公司的完全所有权。该公司预计该交易将于2025年初完成。该交易预计将对GE HealthCare第一年的调整后每股收益产生中性影响，此后将增加收益。

GE HealthCare (Nasdaq: GEHC) has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing from ...

器械之家医疗器械媒体报道先锋分享专业医疗器械知识关注 来源：器械之家，未经授权不得转载，且24小时后方可转载12月2日，GE医疗宣布将从住友化学收购日本领先放射性药物公司Nihon ...

The Chicago-based medical device and technology giant plans to purchase the remaining 50% stake in Nihon Medi-Physics.

GE HealthCare has owned half of Nihon Medi-Physics since 2004, when former parent company General Electric obtained the stake ...

Physics, maker of diagnostic radiopharmaceuticals and molecular imaging agents. | GE HealthCare plans to take full control of ...

GE HealthCare Technologies Inc. (GEHC) announced its agreement to acquire the remaining 50% stake in Nihon Medi-Physics Co., Ltd or ...

GE HealthCare (GEHC) has agreed to acquire full ownership of Nihon Medi-Physics, by purchasing from Sumitomo Chemical the 50% stake it does not ...